TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $235,000 | +30.6% | 14,317 | +33.8% | 0.00% | +33.3% |
| Q2 2021 | $180,000 | -5.3% | 10,699 | +0.2% | 0.00% | -25.0% |
| Q3 2020 | $190,000 | -16.3% | 10,675 | -15.6% | 0.00% | -20.0% |
| Q2 2020 | $227,000 | +14.6% | 12,642 | -3.1% | 0.01% | 0.0% |
| Q1 2020 | $198,000 | -7.5% | 13,052 | +20.4% | 0.01% | +25.0% |
| Q4 2019 | $214,000 | +6.5% | 10,841 | -7.4% | 0.00% | 0.0% |
| Q3 2019 | $201,000 | +3.6% | 11,704 | +6.7% | 0.00% | 0.0% |
| Q2 2019 | $194,000 | – | 10,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |